Neoadjuvant chemotherapy for breast Cancer: evaluation by PET / CT

Abstract

his study was carried out at the department of Radiology, Ain Shams University Hospitals and private centers, Egypt through 9 months, onset in July 2019. The study is a diagnostic retrospective study with convenience sample. The study was approved by the Institutional Ethics and Research committee of the Faculty of Medicine, Ain Shams University, Egypt. All patients were informed of the study procedure, benefits and potential complications and were included in the study after obtaining their informed consent. A total of 30 female patients with breast cancer (age ranged from 27 to 76 years) were participated in this study. The study will be conducted according to the stipulations of the ASU ethical and scientific committee. The privacy of participants and confidentiality of data will be guaranteed during the various phases of the study. In the present study, we have analyzed the role of 18F-FDG PET/CT in detecting the pathological response to neoadjuvant chemotherapy (NAC) in breast cancer (BC) patients in 30 female patients. The evaluation of improvement was assessed by objective methods which were done by SUV max for each patient both at the baseline and after 3 cycles of chemo therapy, along with subjective